REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka "Eskulap" Spj. D. I R. Gargol (Poland)

Main Activities: Department Stores
Full name: Apteka "Eskulap" Spj. D. I R. Gargol Profile Updated: October 13, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apteka "Eskulap" Spj. D. I R. Gargol is a company in Poland, with a head office in Lublin. The company operates in the Department Stores sector. Apteka "Eskulap" Spj. D. I R. Gargol was incorporated on April 03, 2001. There was a net sales revenue drop of 18.87% reported in Apteka "Eskulap" Spj. D. I R. Gargol’s latest financial highlights for 2023. Over the same period, its total assets decreased by 29.72%. The net profit margin of Apteka "Eskulap" Spj. D. I R. Gargol decreased by 4.07% in 2023.

Headquarters
Ul. Obywatelska 9
Lublin; Lubelskie; Postal Code: 20-092

Contact Details: Purchase the Apteka "Eskulap" Spj. D. I R. Gargol report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka "Eskulap" Spj. D. I R. Gargol report to view the information.
Incorporation Date:
April 03, 2001
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteka "Eskulap" Spj. D. I R. Gargol report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-18.87%
Total operating revenue
-20.69%
Operating profit (EBIT)
-77.73%
Net Profit (Loss) for the Period
-77.73%
Total assets
-29.72%
Total equity
-81.23%
Operating Profit Margin (ROS)
-4.07%
Net Profit Margin
-4.07%
Return on Equity (ROE)
-2.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?